Ann: Actinogen awarded UK Innovation Passport for Xanamem, page-27

Hi @thymus,

It's nothing to do with ACW, just me in general.
Struggling. My little boy gets worse everyday. Autism regression. NDIS agent rip-offs ($500 for half an hour). Had no idea was paying this for two years. And, all my other biotech investments have tanked.
It's a good thing, I still have a very good profitable business that I can work when I feel like working.
Anyway, its good to see all you guys back, will jump in soon. As for the UK license. I am not as familiar as OVF. One thing I can say, is that OSL got a CE for their device. Look what they are trading at. An approved product, and they are struggling, because the FDA have ignored them for so long.
One thing, I have learnt, is that there are bigger players in this.